https://scholars.lib.ntu.edu.tw/handle/123456789/495148
標題: | Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13 | 作者: | WEI-CHU CHIE CHIH-HSIN YANG CHIUN HSU PAN-CHYR YANG |
公開日期: | 2004 | 卷: | 13 | 期: | 1 | 起(迄)頁: | 257-262 | 來源出版物: | Quality of Life Research | 摘要: | The purpose of this study was to test the validity and reliability of the Taiwan Chinese translation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30, version 3) and Quality of Life Questionnaire Lung Cancer-13 (QLQ-LC13) questionnaires. Consecutively 51 patients with lung cancer undergoing active chemotherapy and 48 such patients undergoing regular follow-up completed the questionnaires. The intraclass correlation between test and retest ranged from 0.46 to 0.85 for the QLQ-C30 and was 0.76 for dyspnea for the QLQ-LC13. The K coefficients between test and retest ranged from 0.51 to 0.73 for single items of the QLQ-C30 and 0.49-0.68 for five of the nine items in the QLQ-LC13. The Cronbach's α coefficients were ?0.70 for all scales of the two questionnaires apart from that of cognitive functioning. The correlation coefficients between indices measuring similar dimensions of the EORTC QLQ-C30 and the SF-36 questionnaires ranged from 0.43 to 0.73, and that between the dyspnea scales of the two EORTC questionnaires was 0.70. Patients in the follow-up group revealed higher scores of global status/quality of life, and lower scores of nausea/vomiting, as also physical functioning. The questionnaires could also detect expected adverse effects of radiotherapy, cisplatin, and paclitaxel. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-1542315432&doi=10.1023%2fB%3aQURE.0000015295.74812.06&partnerID=40&md5=d645f688092738c9b3398749b3aa8144 https://scholars.lib.ntu.edu.tw/handle/123456789/495148 |
ISSN: | 0962-9343 | DOI: | 10.1023/B:QURE.0000015295.74812.06 | SDG/關鍵字: | antineoplastic agent; cisplatin; paclitaxel; adult; arm disease; article; cancer chemotherapy; cancer patient; cancer radiotherapy; Chinese; cognition; controlled study; correlation analysis; correlation coefficient; dyspnea; Europe; fatigue; female; follow up; hair loss; health care organization; health status; human; lung carcinoma; major clinical study; male; nausea; pain; priority journal; quality of life; questionnaire; reliability; scale up; scoring system; shoulder pain; side effect; Taiwan; treatment outcome; validation process; vomiting; Adult; Antineoplastic Agents; China; Humans; Lung Neoplasms; Middle Aged; Nausea; Psychometrics; Quality of Life; Radiotherapy; Sickness Impact Profile; Taiwan; Translations; Vomiting |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。